Madrigal Pharmaceuticals, Inc. MDGL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$94.39M-61.1% | -$58.58M+48.7% | -$114.19M-170% | -$42.28M+42.3% | -$73.24M-23.3% | ||
| $386K-1.5% | $392K+9.5% | $358K-5.0% | $377K-0.5% | $379K+4.4% | ||
| $34.02M+31.9% | $25.79M-1.8% | $26.25M+4.3% | $25.16M+20.2% | $20.93M+18.4% | ||
| -$167.44M-25.5% | -$133.46M— | —— | -$47.05M+47.1% | -$88.89M+14.9% | ||
| $3.85M— | —— | $857K— | $0— | $0-100% | ||
| $192.19M+597% | $27.58M— | —— | $47.86M-70.8% | $163.88M+442% | ||
| $2.33M-74.0% | $8.96M-96.2% | $236.65M+13,493% | $1.74M-79.8% | $8.64M-56.3% | ||
| $28.41M— | —— | $109.5M+4,199% | $2.55M-97.0% | $83.63M— | ||
| -$171.28M-28.7% | -$133.07M— | —— | -$47.05M+47.1% | -$88.89M+15.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Madrigal Pharmaceuticals, Inc. generate?
- Madrigal Pharmaceuticals, Inc. (MDGL) generated -$436.8M in operating cash flow over the trailing twelve months.
- What is Madrigal Pharmaceuticals, Inc.'s free cash flow?
- After $4.7M of capital expenditures, Madrigal Pharmaceuticals, Inc.'s free cash flow was -$440.3M over the trailing twelve months, up 3.7% year over year.
- Where does Madrigal Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Madrigal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
